Abstract
BackgroundOncolytic viruses (OVs) are capable to inflame the tumor microenvironment (TME) and elicit infiltrating tumor-specific T cell responses. However, OV treatment negatively alters the cancer-immune set point in tumors to...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have